Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008

Uložené v:
Podrobná bibliografia
Názov: Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008
Autori: Ross J. Baldessarini, Edwin Ho Ming Lee, Mian-Yoon Chong, Eun Kee Chung, Kang Sim, Norman Sartorius, Chay Hoon Tan, Senta Fujii, Phern-Chern Tor, Naotaka Shinfuku, Yanling He, Yu-Tao Xiang, Chuanyue Wang, Shu Yu Yang, Pichet Udomratn, J K Trivedi, Gabor S. Ungvari, Kok Yoon Chee, Tian-Mei Si, Kian-Hui Yong, Tze Pin Ng, Ee Heok Kua
Prispievatelia: PSYCHOLOGICAL MEDICINE
Zdroj: The International Journal of Neuropsychopharmacology. 14:735-745
Informácie o vydavateľovi: Oxford University Press (OUP), 2011.
Rok vydania: 2011
Predmety: Adult, Male, Asia, Statistics as Topic, Physician's Practice Patterns, Diagnostic And Statistical Manual Of Mental Disorders, Benzodiazepines, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Humans, Drug Therapy, Combination - Adverse Effects, Statistics As Topic, Practice Patterns, Physicians', Psychotropic Drugs - Administration & Dosage - Adverse Effects - Therapeutic Use, Aged, Psychotropic Drugs, Benzodiazepines - Administration & Dosage - Adverse Effects - Therapeutic Use, Combination - Adverse Effects, Middle Aged, Practice Guidelines As Topic, 3. Good health, Diagnostic and Statistical Manual of Mental Disorders, Hospitalization, Cross-Sectional Studies, Practice Guidelines as Topic, Schizophrenia, Drug Therapy, Combination, Female, Schizophrenia - Drug Therapy - Physiopathology
Popis: Benzodiazepines are commonly prescribed to patients with schizophrenia in many countries, but as little is known about such treatment in Asia, we evaluated their adjunctive use for 6761 in-patients diagnosed with schizophrenia in nine Asian countries using a cross-sectional study design in 2001, 2004 and 2008. Multivariate logistic regression and multivariate linear regression analyses were performed to assess predictors of benzodiazepine use and dose, respectively. Overall, 54% of the patients received adjunctive benzodiazepines at an average daily dose equivalent to 30.3 mg diazepam, with minor changes over the years sampled. Benzodiazepine use was highest in Taiwan and Japan, lowest in Thailand and China, and was associated with fewer years ill, presence of delusions (OR 1.24), hallucinations (OR 1.22), disorganized speech (OR 1.17), social or occupational dysfunction (OR 1.16), and use of mood stabilizers (OR 3.15), antiparkinsonian (OR 1.79) or antidepressant drugs (OR 1.33), and lower doses of antipsychotics (all p=0.016 to
Druh dokumentu: Article
Jazyk: English
ISSN: 1469-5111
1461-1457
DOI: 10.1017/s146114571000163x
Prístupová URL adresa: https://academic.oup.com/ijnp/article-pdf/14/6/735/2713448/14-6-735.pdf
https://pubmed.ncbi.nlm.nih.gov/21294941
https://europepmc.org/article/MED/21294941
https://academic.oup.com/ijnp/article/14/6/735/916161
https://hub.hku.hk/handle/10722/171963
http://hub.hku.hk/bitstream/10722/171963/1/Content.pdf
https://pubmed.ncbi.nlm.nih.gov/21294941/
https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201302297590930854
http://hdl.handle.net/10722/171963
Rights: implied-oa
CC BY NC ND
Prístupové číslo: edsair.doi.dedup.....f7a37fcc71923ec8cb2c5fa992172af2
Databáza: OpenAIRE
Popis
Abstrakt:Benzodiazepines are commonly prescribed to patients with schizophrenia in many countries, but as little is known about such treatment in Asia, we evaluated their adjunctive use for 6761 in-patients diagnosed with schizophrenia in nine Asian countries using a cross-sectional study design in 2001, 2004 and 2008. Multivariate logistic regression and multivariate linear regression analyses were performed to assess predictors of benzodiazepine use and dose, respectively. Overall, 54% of the patients received adjunctive benzodiazepines at an average daily dose equivalent to 30.3 mg diazepam, with minor changes over the years sampled. Benzodiazepine use was highest in Taiwan and Japan, lowest in Thailand and China, and was associated with fewer years ill, presence of delusions (OR 1.24), hallucinations (OR 1.22), disorganized speech (OR 1.17), social or occupational dysfunction (OR 1.16), and use of mood stabilizers (OR 3.15), antiparkinsonian (OR 1.79) or antidepressant drugs (OR 1.33), and lower doses of antipsychotics (all p=0.016 to
ISSN:14695111
14611457
DOI:10.1017/s146114571000163x